Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | EPISURF MEDICAL AB: DNB Markets - Episurf Medical: New US distributor agreement | 2 | Cision News | ||
Mi | Episurf Medical AB: Interim report 1 January - 31 March 2024 | 70 | GlobeNewswire (Europe) | • Reduced cost base following implementation of restructuring programme
• Ongoing regulatory process targeting 510(k)-clearance Episealer® MTP-System
• Largest distribution agreement to date in the... ► Artikel lesen | |
Mo | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
09.04. | SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB (PUBL) | 1 | Cision News | ||
07.03. | Episurf Medical AB's 2023 annual report is now available | 1 | Cision News | ||
05.03. | Episurf Medical to present at Life Sciencedagen on March 6, 2024 | 1 | Cision News | ||
05.03. | Notice of Annual General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
04.03. | Nomination Committee's proposal regarding board of directors of Episurf Medical AB for 2024 | 1 | Cision News | ||
13.02. | EPISURF MEDICAL AB: DNB Markets - Episurf Medical: Sales moving in the right direction | 1 | Cision News | ||
09.02. | Episurf Medical AB: Year-End Report 1 January - 31 December 2023 | 2 | GlobeNewswire (Europe) | Continued stable growth despite restructuring of commercial organization, and satisfactory start in the US with significant opportunities ahead
Restructuring program completed with planned cost... ► Artikel lesen | |
16.01. | EPISURF: Results from up to 10 years follow-up of Episealer® patients accepted for presentation at international orthopaedic congress | 1 | Cision News | ||
28.11.23 | New patent approvals for Episurf Medical | 1 | Cision News | ||
23.11.23 | Episurf Medical to present at Redeye Life Science Day on November 23rd, 2023 | 1 | Cision News | ||
27.10.23 | Episurf Medical AB: Interim Report 1 January - 30 September 2023 | 6 | GlobeNewswire (Europe) | US: Commercial business started promising with the first surgeries performed. 510(k) application for Episealer® MTP-system submitted
OUS: Continued steady growth driven by continued strong growth... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
IMUNON | 1,250 | -6,72 % | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen | |
ELECTROCORE | 5,400 | 0,00 % | electroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2023 Financial Results | Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J.... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,30 | -0,87 % | DAX im Minus, Nahost-Lage spitzt sich zu: Rheinmetall, Lufthansa, Siemens Healthineers, TUI ... | Nachdem der DAX am Donnerstag noch freundlich mit einem Plus von 0,4 Prozent auf 17.837,40 Zählern aus dem Handel gegangen war, zeichnet sich für den letzten Handelstag der Woche ein kräftiges Minus... ► Artikel lesen | |
FRESENIUS | 27,180 | -0,51 % | Fresenius: Aktie knackt Hürde - wichtige Termine voraus | Die Aktie von Fresenius kommt immer mehr in Fahrt. Am heutigen Montag gewinnt das Papier weitere 1,2 Prozent auf 27,21 Euro, nachdem Fresenius in den vergangenen Wochen bereits deutlich zulegen konnte.... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 52,28 | -0,38 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
FRESENIUS MEDICAL CARE | 37,790 | -3,00 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC vor Quartalszahlen auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. Nach einem Gespräch mit der Investor-Relations-Abteilung... ► Artikel lesen | |
GERRESHEIMER | 99,20 | -2,17 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
CARL ZEISS MEDITEC | 99,00 | -1,39 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROGYNY | 32,500 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
RXSIGHT | 51,89 | -1,80 % | RxSight, Inc. - 8-K, Current Report | ||
PRIVIA HEALTH GROUP | 17,990 | -0,99 % | Where Privia Health Gr Stands With Analysts | ||
MIMEDX | 6,245 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,780 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
IMAC HOLDINGS | 5,100 | 0,00 % | (BACK) - Analyzing IMAC Holdings' Short Interest | ||
ATRICURE | 22,610 | -1,91 % | AtriCure upgraded at Oppenheimer on valuation |